#

SUBJECT EXPERT COMMITTEE

Bharat Biotech Asked For More Data By DCGI For Authorising Covaxin To Children Under 12

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report
Coronavirus HIGHLIGHTS | Subject Expert Committee Recommends Sputnik Light One-Shot Vaccine: Report
Amid Omicron Fear, Expert Committee Gives No Recommendations For COVID Booster Dose: Report
Omicron Scare: Subject Expert Committee To Hold Meeting Tomorrow Over Booster Doses

Bharat Biotech Gets Approval To Start Next Phase Of Clinical Trials Of 'Covaxin' On Children Aged 2-18 Years
- Tags:
- coronavirus
- Bharat Biotech
- covaxin

Expert Panel Gives Nod To Bharat Biotech’s Covaxin For Restricted Emergency Use

Prev
1
Next

About us | Advertisement| Privacy policy

© Copyright@2024.ABP Network Private Limited. All rights reserved.